The CITIC Securities Research Report points out that it is optimistic about the transfer opportunities of Chinese drug sales channels from hospital to hospital and from offline to online. Under the wave of medical insurance fee control, the migration of original drug research channels, and the popularity of AI search and promotion, the online sales rate of healthcare products is expected to rise significantly; leading pharmaceutical e-commerce businesses have stable advantages in main site endowments, traffic, and fulfillment costs, and are expected to seize new opportunities for AI search and health management with AI R&D and commercialization capabilities.

The CITIC Securities Research Report points out that it is optimistic about the transfer opportunities of Chinese drug sales channels from hospital to hospital and from offline to online. Under the wave of medical insurance fee control, the migration of original drug research channels, and the popularity of AI search and promotion, the online sales rate of healthcare products is expected to rise significantly; leading pharmaceutical e-commerce businesses have stable advantages in main site endowments, traffic, and fulfillment costs, and are expected to seize new opportunities for AI search and health management with AI R&D and commercialization capabilities.